 id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">WHO (2014) Global Health Observatory (GHO) data. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/gho/hiv/en/">http://www.who.int/gho/hiv/en/</ext-link></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">WHO (2014) World Health Organization: Global Tuberculosis Report 2014. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tb/publications/global_report/en/">http://www.who.int/tb/publications/global_report/en/</ext-link></mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kony</surname><given-names>SJ</given-names></name><name><surname>Hane</surname><given-names>AA</given-names></name><name><surname>Larouze</surname><given-names>B</given-names></name><name><surname>Samb</surname><given-names>A</given-names></name><name><surname>Cissoko</surname><given-names>S</given-names></name><name><surname>Sow</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Tuberculosis-associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar. SIDAK Research Group</article-title><source>J Infect</source><year>2000</year><volume>41</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1053/jinf.2000.0721</pub-id><?supplied-pmid 11023763?><pub-id pub-id-type="pmid">11023763</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilheu</surname><given-names>JA</given-names></name><name><surname>De Salvo</surname><given-names>MC</given-names></name><name><surname>Gonzalez</surname><given-names>J</given-names></name><name><surname>Rey</surname><given-names>D</given-names></name><name><surname>Elias</surname><given-names>MC</given-names></name><name><surname>Ruppi</surname><given-names>MC</given-names></name></person-group><article-title>CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection</article-title><source>Int J Tuberc Lung Dis</source><year>1997</year><volume>1</volume><fpage>422</fpage><lpage>426</lpage><?supplied-pmid 9441096?><pub-id pub-id-type="pmid">9441096</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whalen</surname><given-names>C</given-names></name><name><surname>Horsburgh</surname><given-names>CR</given-names></name><name><surname>Hom</surname><given-names>D</given-names></name><name><surname>Lahart</surname><given-names>C</given-names></name><name><surname>Simberkoff</surname><given-names>M</given-names></name><name><surname>Ellner</surname><given-names>J</given-names></name></person-group><article-title>Accelerated course of human immunodeficiency virus infection after tuberculosis</article-title><source>Am J Respir Crit Care Med</source><year>1995</year><volume>151</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.151.1.7812542</pub-id><?supplied-pmid 7812542?><pub-id pub-id-type="pmid">7812542</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">WHO (2015) A guide to monitoring and evaluation for collaborative TB/HIV activities. <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/150627/1/9789241508278_eng.pdf?ua=1">http://apps.who.int/iris/bitstream/10665/150627/1/9789241508278_eng.pdf?ua=1</ext-link></mixed-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diedrich</surname><given-names>CR</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group><article-title>HIV-1/<italic>Mycobacterium tuberculosis</italic> coinfection immunology: how does HIV-1 exacerbate tuberculosis?</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>1407</fpage><lpage>1417</lpage><pub-id pub-id-type="doi">10.1128/IAI.01126-10</pub-id><?supplied-pmid 21245275?><pub-id pub-id-type="pmid">21245275</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Hoshino</surname><given-names>S</given-names></name><name><surname>Gold</surname><given-names>JA</given-names></name><name><surname>Raju</surname><given-names>B</given-names></name><name><surname>Prabhakar</surname><given-names>S</given-names></name><name><surname>Pine</surname><given-names>R</given-names></name><etal/></person-group><article-title>Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis</article-title><source>J Infect Dis</source><year>2007</year><volume>195</volume><fpage>1303</fpage><lpage>1310</lpage><pub-id pub-id-type="doi">10.1086/513438</pub-id><?supplied-pmid 17396999?><pub-id pub-id-type="pmid">17396999</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Nakata</surname><given-names>K</given-names></name><name><surname>Hoshino</surname><given-names>S</given-names></name><name><surname>Honda</surname><given-names>Y</given-names></name><name><surname>Tse</surname><given-names>DB</given-names></name><name><surname>Shioda</surname><given-names>T</given-names></name><etal/></person-group><article-title>Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1084/jem.20011614</pub-id><?supplied-pmid 11854362?><pub-id pub-id-type="pmid">11854362</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Pisell</surname><given-names>TL</given-names></name><name><surname>Hirsch</surname><given-names>CS</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Butera</surname><given-names>ST</given-names></name><name><surname>Toossi</surname><given-names>Z</given-names></name></person-group><article-title>Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection</article-title><source>J Infect Dis</source><year>2001</year><volume>184</volume><fpage>1127</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1086/323649</pub-id><?supplied-pmid 11598835?><pub-id pub-id-type="pmid">11598835</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakata</surname><given-names>K</given-names></name><name><surname>Rom</surname><given-names>WN</given-names></name><name><surname>Honda</surname><given-names>Y</given-names></name><name><surname>Condos</surname><given-names>R</given-names></name><name><surname>Kanegasaki</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><etal/></person-group><article-title><italic>Mycobacterium tuberculosis</italic> enhances human immunodeficiency virus-1 replication in the lung</article-title><source>Am J Respir Crit Care Med</source><year>1997</year><volume>155</volume><fpage>996</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.155.3.9117038</pub-id><?supplied-pmid 9117038?><pub-id pub-id-type="pmid">9117038</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumawat</surname><given-names>K</given-names></name><name><surname>Pathak</surname><given-names>SK</given-names></name><name><surname>Spetz</surname><given-names>AL</given-names></name><name><surname>Kundu</surname><given-names>M</given-names></name><name><surname>Basu</surname><given-names>J</given-names></name></person-group><article-title>Exogenous Nef is an inhibitor of <italic>Mycobacterium tuberculosis</italic>-induced tumor necrosis factor-alpha production and macrophage apoptosis</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>12629</fpage><lpage>12637</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.073320</pub-id><?supplied-pmid 20068037?><pub-id pub-id-type="pmid">20068037</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>NR</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Tachado</surname><given-names>SD</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>Z</given-names></name><name><surname>Saukkonen</surname><given-names>J</given-names></name><etal/></person-group><article-title>HIV impairs TNF-alpha mediated macrophage apoptotic response to <italic>Mycobacterium tuberculosis</italic></article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>6973</fpage><lpage>6980</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.10.6973</pub-id><?supplied-pmid 17982088?><pub-id pub-id-type="pmid">17982088</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geldmacher</surname><given-names>C</given-names></name><name><surname>Schuetz</surname><given-names>A</given-names></name><name><surname>Ngwenyama</surname><given-names>N</given-names></name><name><surname>Casazza</surname><given-names>JP</given-names></name><name><surname>Sanga</surname><given-names>E</given-names></name><name><surname>Saathoff</surname><given-names>E</given-names></name><etal/></person-group><article-title>Early depletion of <italic>Mycobacterium tuberculosis</italic>-specific T helper 1 cell responses after HIV-1 infection</article-title><source>J Infect Dis</source><year>2008</year><volume>198</volume><fpage>1590</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1086/593017</pub-id><?supplied-pmid 19000013?><pub-id pub-id-type="pmid">19000013</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertoghe</surname><given-names>T</given-names></name><name><surname>Wajja</surname><given-names>A</given-names></name><name><surname>Ntambi</surname><given-names>L</given-names></name><name><surname>Okwera</surname><given-names>A</given-names></name><name><surname>Aziz</surname><given-names>MA</given-names></name><name><surname>Hirsch</surname><given-names>C</given-names></name><etal/></person-group><article-title>T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB)</article-title><source>Clin Exp Immunol</source><year>2000</year><volume>122</volume><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.2000.01385.x</pub-id><?supplied-pmid 11122240?><pub-id pub-id-type="pmid">11122240</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalsdorf</surname><given-names>B</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Wood</surname><given-names>K</given-names></name><name><surname>Day</surname><given-names>CL</given-names></name><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Dawson</surname><given-names>R</given-names></name><etal/></person-group><article-title>HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>180</volume><fpage>1262</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1164/rccm.200907-1011OC</pub-id><?supplied-pmid 19797156?><pub-id pub-id-type="pmid">19797156</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendonca</surname><given-names>M</given-names></name><name><surname>Tanji</surname><given-names>MM</given-names></name><name><surname>Silva</surname><given-names>LC</given-names></name><name><surname>Silveira</surname><given-names>GG</given-names></name><name><surname>Oliveira</surname><given-names>SC</given-names></name><name><surname>Duarte</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Deficient in vitro anti-mycobacterial immunity despite successful long-term highly active antiretroviral therapy in HIV-infected patients with past history of tuberculosis infection or disease</article-title><source>Clin Immunol</source><year>2007</year><volume>125</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2007.06.002</pub-id><?supplied-pmid 17631053?><pub-id pub-id-type="pmid">17631053</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Iyer</surname><given-names>DV</given-names></name><name><surname>Jones</surname><given-names>BE</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name><name><surname>Barnes</surname><given-names>PF</given-names></name></person-group><article-title>T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection</article-title><source>J Clin Invest</source><year>1994</year><volume>94</volume><fpage>2435</fpage><lpage>2442</lpage><pub-id pub-id-type="doi">10.1172/JCI117611</pub-id><?supplied-pmid 7989601?><pub-id pub-id-type="pmid">7989601</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suthar</surname><given-names>AB</given-names></name><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>del Amo</surname><given-names>J</given-names></name><name><surname>Getahun</surname><given-names>H</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name><name><surname>Sculier</surname><given-names>D</given-names></name><etal/></person-group><article-title>Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis</article-title><source>PLoS Med</source><year>2012</year><volume>9</volume><pub-id pub-id-type="doi">10.1371/journal.pmed.1001270</pub-id><?supplied-pmid 22911011?><pub-id pub-id-type="pmid">22911011</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Autran</surname><given-names>B</given-names></name><name><surname>Carcelain</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>TS</given-names></name><name><surname>Blanc</surname><given-names>C</given-names></name><name><surname>Mathez</surname><given-names>D</given-names></name><name><surname>Tubiana</surname><given-names>R</given-names></name><etal/></person-group><article-title>Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease</article-title><source>Science</source><year>1997</year><volume>277</volume><fpage>112</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1126/science.277.5322.112</pub-id><?supplied-pmid 9204894?><pub-id pub-id-type="pmid">9204894</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Seldon</surname><given-names>R</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Hanekom</surname><given-names>WA</given-names></name><name><surname>Maartens</surname><given-names>G</given-names></name><etal/></person-group><article-title>Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by <italic>Mycobacterium tuberculosis</italic></article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>180</volume><fpage>674</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1164/rccm.200904-0568OC</pub-id><?supplied-pmid 19628776?><pub-id pub-id-type="pmid">19628776</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>JS</given-names></name><name><surname>Young</surname><given-names>JM</given-names></name><name><surname>Peterson</surname><given-names>KL</given-names></name><name><surname>Sanneh</surname><given-names>B</given-names></name><name><surname>Whittle</surname><given-names>HC</given-names></name><name><surname>Rowland-Jones</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><fpage>6537</fpage><lpage>6544</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000399</pub-id><?supplied-pmid 20435929?><pub-id pub-id-type="pmid">20435929</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>MA</given-names></name><name><surname>Mallal</surname><given-names>SA</given-names></name><name><surname>Dawkins</surname><given-names>RL</given-names></name></person-group><article-title>Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients</article-title><source>Aids</source><year>1992</year><volume>6</volume><fpage>1293</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1097/00002030-199211000-00009</pub-id><?supplied-pmid 1472334?><pub-id pub-id-type="pmid">1472334</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Bekker</surname><given-names>LG</given-names></name><name><surname>Miller</surname><given-names>RF</given-names></name></person-group><article-title>Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70140-7</pub-id><?supplied-pmid 15919622?><pub-id pub-id-type="pmid">15919622</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Wandel</surname><given-names>S</given-names></name><name><surname>Colebunders</surname><given-names>R</given-names></name><name><surname>Attia</surname><given-names>S</given-names></name><name><surname>Furrer</surname><given-names>H</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name><etal/></person-group><article-title>Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis</article-title><source>Lancet Infect Dis</source><year>2010</year><volume>10</volume><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(10)70026-8</pub-id><?supplied-pmid 20334848?><pub-id pub-id-type="pmid">20334848</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namale</surname><given-names>PE</given-names></name><name><surname>Abdullahi</surname><given-names>LH</given-names></name><name><surname>Fine</surname><given-names>S</given-names></name><name><surname>Kamkuemah</surname><given-names>M</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name></person-group><article-title>Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis</article-title><source>Future Microbiol</source><year>2015</year><volume>10</volume><fpage>1077</fpage><lpage>1099</lpage><pub-id pub-id-type="doi">10.2217/fmb.15.9</pub-id><?supplied-pmid 26059627?><pub-id pub-id-type="pmid">26059627</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marais</surname><given-names>S</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Pepper</surname><given-names>DJ</given-names></name><name><surname>Dodd</surname><given-names>LE</given-names></name><name><surname>Schutz</surname><given-names>C</given-names></name><name><surname>Ismail</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome</article-title><source>Clin Infect Dis</source><year>2013</year><volume>56</volume><fpage>450</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1093/cid/cis899</pub-id><?supplied-pmid 23097584?><pub-id pub-id-type="pmid">23097584</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asselman</surname><given-names>V</given-names></name><name><surname>Thienemann</surname><given-names>F</given-names></name><name><surname>Pepper</surname><given-names>DJ</given-names></name><name><surname>Boulle</surname><given-names>A</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><etal/></person-group><article-title>Central nervous system disorders after starting antiretroviral therapy in South Africa</article-title><source>Aids</source><year>2010</year><volume>24</volume><fpage>2871</fpage><lpage>2876</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e328340fe76</pub-id><?supplied-pmid 21045634?><pub-id pub-id-type="pmid">21045634</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepper</surname><given-names>DJ</given-names></name><name><surname>Marais</surname><given-names>S</given-names></name><name><surname>Maartens</surname><given-names>G</given-names></name><name><surname>Rebe</surname><given-names>K</given-names></name><name><surname>Morroni</surname><given-names>C</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><etal/></person-group><article-title>Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><fpage>e96</fpage><lpage>e107</lpage><pub-id pub-id-type="doi">10.1086/598988</pub-id><?supplied-pmid 19405867?><pub-id pub-id-type="pmid">19405867</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colebunders</surname><given-names>R</given-names></name><name><surname>John</surname><given-names>L</given-names></name><name><surname>Huyst</surname><given-names>V</given-names></name><name><surname>Kambugu</surname><given-names>A</given-names></name><name><surname>Scano</surname><given-names>F</given-names></name><name><surname>Lynen</surname><given-names>L</given-names></name></person-group><article-title>Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources</article-title><source>Int J Tuberc Lung Dis</source><year>2006</year><volume>10</volume><fpage>946</fpage><lpage>953</lpage><?supplied-pmid 16964782?><pub-id pub-id-type="pmid">16964782</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>MA</given-names></name><name><surname>Price</surname><given-names>P</given-names></name><name><surname>Stone</surname><given-names>SF</given-names></name></person-group><article-title>Immune restoration disease after antiretroviral therapy</article-title><source>Aids</source><year>2004</year><volume>18</volume><fpage>1615</fpage><lpage>1627</lpage><pub-id pub-id-type="doi">10.1097/01.aids.0000131375.21070.06</pub-id><?supplied-pmid 15280772?><pub-id pub-id-type="pmid">15280772</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>J</given-names></name><name><surname>Meier</surname><given-names>M</given-names></name><name><surname>Wall</surname><given-names>J</given-names></name><name><surname>Ying</surname><given-names>J</given-names></name><name><surname>Fichtenbaum</surname><given-names>CJ</given-names></name></person-group><article-title>Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy</article-title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>1639</fpage><lpage>1646</lpage><pub-id pub-id-type="doi">10.1086/503903</pub-id><?supplied-pmid 16652323?><pub-id pub-id-type="pmid">16652323</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelburne</surname><given-names>SA</given-names><suffix>3rd</suffix></name><name><surname>Hamill</surname><given-names>RJ</given-names></name><name><surname>Rodriguez-Barradas</surname><given-names>MC</given-names></name><name><surname>Greenberg</surname><given-names>SB</given-names></name><name><surname>Atmar</surname><given-names>RL</given-names></name><name><surname>Musher</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy</article-title><source>Medicine</source><year>2002</year><volume>81</volume><fpage>213</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1097/00005792-200205000-00005</pub-id><?supplied-pmid 11997718?><pub-id pub-id-type="pmid">11997718</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelburne</surname><given-names>SA</given-names></name><name><surname>Montes</surname><given-names>M</given-names></name><name><surname>Hamill</surname><given-names>RJ</given-names></name></person-group><article-title>Immune reconstitution inflammatory syndrome: more answers, more questions</article-title><source>J Antimicrob Chem</source><year>2006</year><volume>57</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1093/jac/dki444</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Scano</surname><given-names>F</given-names></name><name><surname>Maartens</surname><given-names>G</given-names></name><name><surname>French</surname><given-names>MA</given-names></name><name><surname>Worodria</surname><given-names>W</given-names></name><etal/></person-group><article-title>Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings</article-title><source>Lancet Infect Dis</source><year>2008</year><volume>8</volume><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(08)70184-1</pub-id><?supplied-pmid 18652998?><pub-id pub-id-type="pmid">18652998</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshun-Wilson</surname><given-names>I</given-names></name><name><surname>Havers</surname><given-names>F</given-names></name><name><surname>Nachega</surname><given-names>JB</given-names></name><name><surname>Prozesky</surname><given-names>HW</given-names></name><name><surname>Taljaard</surname><given-names>JJ</given-names></name><name><surname>Zeier</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings</article-title><source>J Int Assoc Phys AIDS Care</source><year>2010</year><volume>9</volume><fpage>104</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1177/1545109710361537</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddow</surname><given-names>LJ</given-names></name><name><surname>Moosa</surname><given-names>MY</given-names></name><name><surname>Easterbrook</surname><given-names>PJ</given-names></name></person-group><article-title>Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>Aids</source><year>2010</year><volume>24</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e32832ec1f4</pub-id><?supplied-pmid 19926965?><pub-id pub-id-type="pmid">19926965</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddow</surname><given-names>LJ</given-names></name><name><surname>Easterbrook</surname><given-names>PJ</given-names></name><name><surname>Mosam</surname><given-names>A</given-names></name><name><surname>Khanyile</surname><given-names>NG</given-names></name><name><surname>Parboosing</surname><given-names>R</given-names></name><name><surname>Moodley</surname><given-names>P</given-names></name><etal/></person-group><article-title>Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort</article-title><source>Clin Infect Dis</source><year>2009</year><volume>49</volume><fpage>1424</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.1086/630208</pub-id><?supplied-pmid 19788360?><pub-id pub-id-type="pmid">19788360</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>SK</given-names></name><name><surname>Dhooria</surname><given-names>S</given-names></name><name><surname>Barwad</surname><given-names>P</given-names></name><name><surname>Kadhiravan</surname><given-names>T</given-names></name><name><surname>Ranjan</surname><given-names>S</given-names></name><name><surname>Miglani</surname><given-names>S</given-names></name><etal/></person-group><article-title>A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition</article-title><source>Indian J Med Res</source><year>2010</year><volume>131</volume><fpage>804</fpage><lpage>808</lpage><?supplied-pmid 20571170?><pub-id pub-id-type="pmid">20571170</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>MA</given-names></name><name><surname>Lenzo</surname><given-names>N</given-names></name><name><surname>John</surname><given-names>M</given-names></name><name><surname>Mallal</surname><given-names>SA</given-names></name><name><surname>McKinnon</surname><given-names>EJ</given-names></name><name><surname>James</surname><given-names>IR</given-names></name><etal/></person-group><article-title>Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy</article-title><source>HIV Med</source><year>2000</year><volume>1</volume><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1046/j.1468-1293.2000.00012.x</pub-id><?supplied-pmid 11737333?><pub-id pub-id-type="pmid">11737333</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jevtovic</surname><given-names>DJ</given-names></name><name><surname>Salemovic</surname><given-names>D</given-names></name><name><surname>Ranin</surname><given-names>J</given-names></name><name><surname>Pesic</surname><given-names>I</given-names></name><name><surname>Zerjav</surname><given-names>S</given-names></name><name><surname>Djurkovic-Djakovic</surname><given-names>O</given-names></name></person-group><article-title>The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy</article-title><source>HIV Med</source><year>2005</year><volume>6</volume><fpage>140</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1293.2005.00277.x</pub-id><?supplied-pmid 15807721?><pub-id pub-id-type="pmid">15807721</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Myer</surname><given-names>L</given-names></name><name><surname>Bekker</surname><given-names>LG</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name></person-group><article-title>Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa</article-title><source>Aids</source><year>2007</year><volume>21</volume><fpage>335</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e328011efac</pub-id><?supplied-pmid 17255740?><pub-id pub-id-type="pmid">17255740</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratnam</surname><given-names>I</given-names></name><name><surname>Chiu</surname><given-names>C</given-names></name><name><surname>Kandala</surname><given-names>NB</given-names></name><name><surname>Easterbrook</surname><given-names>PJ</given-names></name></person-group><article-title>Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort</article-title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>418</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1086/499356</pub-id><?supplied-pmid 16392092?><pub-id pub-id-type="pmid">16392092</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgarit</surname><given-names>A</given-names></name><name><surname>Carcelain</surname><given-names>G</given-names></name><name><surname>Martinez</surname><given-names>V</given-names></name><name><surname>Lascoux</surname><given-names>C</given-names></name><name><surname>Delcey</surname><given-names>V</given-names></name><name><surname>Gicquel</surname><given-names>B</given-names></name><etal/></person-group><article-title>Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients</article-title><source>Aids</source><year>2006</year><volume>20</volume><fpage>F1</fpage><lpage>F7</lpage><pub-id pub-id-type="doi">10.1097/01.aids.0000202648.18526.bf</pub-id><?supplied-pmid 16511406?><pub-id pub-id-type="pmid">16511406</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdool Karim</surname><given-names>SS</given-names></name><name><surname>Naidoo</surname><given-names>K</given-names></name><name><surname>Grobler</surname><given-names>A</given-names></name><name><surname>Padayatchi</surname><given-names>N</given-names></name><name><surname>Baxter</surname><given-names>C</given-names></name><name><surname>Gray</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Integration of antiretroviral therapy with tuberculosis treatment</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>1492</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1014181</pub-id><?supplied-pmid 22010915?><pub-id pub-id-type="pmid">22010915</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanc</surname><given-names>FX</given-names></name><name><surname>Sok</surname><given-names>T</given-names></name><name><surname>Laureillard</surname><given-names>D</given-names></name><name><surname>Borand</surname><given-names>L</given-names></name><name><surname>Rekacewicz</surname><given-names>C</given-names></name><name><surname>Nerrienet</surname><given-names>E</given-names></name><etal/></person-group><article-title>Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>1471</fpage><lpage>1481</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1013911</pub-id><?supplied-pmid 22010913?><pub-id pub-id-type="pmid">22010913</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havlir</surname><given-names>DV</given-names></name><name><surname>Kendall</surname><given-names>MA</given-names></name><name><surname>Ive</surname><given-names>P</given-names></name><name><surname>Kumwenda</surname><given-names>J</given-names></name><name><surname>Swindells</surname><given-names>S</given-names></name><name><surname>Qasba</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Timing of antiretroviral therapy for HIV-1 infection and tuberculosis</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>1482</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1013607</pub-id><?supplied-pmid 22010914?><pub-id pub-id-type="pmid">22010914</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burman</surname><given-names>W</given-names></name><name><surname>Weis</surname><given-names>S</given-names></name><name><surname>Vernon</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Benator</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>B</given-names></name><etal/></person-group><article-title>Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis</article-title><source>Int J Tuberc Lung Dis</source><year>2007</year><volume>11</volume><fpage>1282</fpage><lpage>1289</lpage><?supplied-pmid 18229435?><pub-id pub-id-type="pmid">18229435</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manosuthi</surname><given-names>W</given-names></name><name><surname>Kiertiburanakul</surname><given-names>S</given-names></name><name><surname>Phoorisri</surname><given-names>T</given-names></name><name><surname>Sungkanuparph</surname><given-names>S</given-names></name></person-group><article-title>Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy</article-title><source>J Infect</source><year>2006</year><volume>53</volume><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2006.01.002</pub-id><?supplied-pmid 16487593?><pub-id pub-id-type="pmid">16487593</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benson</surname><given-names>CA</given-names></name><name><surname>Kaplan</surname><given-names>JE</given-names></name><name><surname>Masur</surname><given-names>H</given-names></name><name><surname>Pau</surname><given-names>A</given-names></name><name><surname>Holmes</surname><given-names>KK</given-names></name><collab>Cdc</collab><etal/></person-group><article-title>Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America</article-title><source>MMWR Recommend Rep</source><year>2004</year><volume>53</volume><fpage>1</fpage><lpage>112</lpage></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumberg</surname><given-names>HM</given-names></name><name><surname>Burman</surname><given-names>WJ</given-names></name><name><surname>Chaisson</surname><given-names>RE</given-names></name><name><surname>Daley</surname><given-names>CL</given-names></name><name><surname>Etkind</surname><given-names>SC</given-names></name><name><surname>Friedman</surname><given-names>LN</given-names></name><etal/></person-group><article-title>American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><fpage>603</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1164/rccm.167.4.603</pub-id><?supplied-pmid 12588714?><pub-id pub-id-type="pmid">12588714</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breen</surname><given-names>RA</given-names></name><name><surname>Smith</surname><given-names>CJ</given-names></name><name><surname>Bettinson</surname><given-names>H</given-names></name><name><surname>Dart</surname><given-names>S</given-names></name><name><surname>Bannister</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection</article-title><source>Thorax</source><year>2004</year><volume>59</volume><fpage>704</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1136/thx.2003.019224</pub-id><?supplied-pmid 15282393?><pub-id pub-id-type="pmid">15282393</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Morroni</surname><given-names>C</given-names></name><name><surname>Pepper</surname><given-names>DJ</given-names></name><name><surname>Rebe</surname><given-names>K</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><etal/></person-group><article-title>Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>Aids</source><year>2010</year><volume>24</volume><fpage>2381</fpage><lpage>2390</lpage><?supplied-pmid 20808204?><pub-id pub-id-type="pmid">20808204</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Skolimowska</surname><given-names>KH</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Matthews</surname><given-names>K</given-names></name><name><surname>Tadokera</surname><given-names>R</given-names></name><name><surname>Conesa-Botella</surname><given-names>A</given-names></name><etal/></person-group><article-title>Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>186</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1164/rccm.201201-0094OC</pub-id><?supplied-pmid 22700860?><pub-id pub-id-type="pmid">22700860</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>AM</given-names></name><name><surname>Luzze</surname><given-names>H</given-names></name><name><surname>Quigley</surname><given-names>MA</given-names></name><name><surname>Nakiyingi</surname><given-names>JS</given-names></name><name><surname>Kyaligonza</surname><given-names>S</given-names></name><name><surname>Namujju</surname><given-names>PB</given-names></name><etal/></person-group><article-title>A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis</article-title><source>J Infect Dis</source><year>2004</year><volume>190</volume><fpage>869</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1086/422257</pub-id><?supplied-pmid 15295690?><pub-id pub-id-type="pmid">15295690</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>PF</given-names></name><name><surname>Cornejo</surname><given-names>P</given-names></name><name><surname>Zinser</surname><given-names>JW</given-names></name><name><surname>Ormsby</surname><given-names>CE</given-names></name><name><surname>Reyes-Teran</surname><given-names>G</given-names></name></person-group><article-title>Life-threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome</article-title><source>Aids</source><year>2008</year><volume>22</volume><fpage>663</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e3282f4f223</pub-id><?supplied-pmid 18317012?><pub-id pub-id-type="pmid">18317012</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Maartens</surname><given-names>G</given-names></name><name><surname>Rebe</surname><given-names>K</given-names></name><name><surname>Morroni</surname><given-names>C</given-names></name><name><surname>Pepper</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><fpage>667</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1086/596764</pub-id><?supplied-pmid 19191655?><pub-id pub-id-type="pmid">19191655</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">AIDSInfo (2009) Guidelines for prevention and treatment of opportunistic Infections in HIV-infected adults and adolescents</mixed-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>MT</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>P</given-names></name><name><surname>Carmichael</surname><given-names>A</given-names></name><name><surname>Lever</surname><given-names>AM</given-names></name></person-group><article-title>The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports</article-title><source>J Infect</source><year>2003</year><volume>47</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/S0163-4453(03)00077-X</pub-id><?supplied-pmid 12963389?><pub-id pub-id-type="pmid">12963389</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoeman</surname><given-names>JF</given-names></name><name><surname>Fieggen</surname><given-names>G</given-names></name><name><surname>Seller</surname><given-names>N</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Hartzenberg</surname><given-names>B</given-names></name></person-group><article-title>Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases</article-title><source>J Child Neurol</source><year>2006</year><volume>21</volume><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1177/08830738060210040801</pub-id><?supplied-pmid 16900926?><pub-id pub-id-type="pmid">16900926</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunel</surname><given-names>AS</given-names></name><name><surname>Reynes</surname><given-names>J</given-names></name><name><surname>Tuaillon</surname><given-names>E</given-names></name><name><surname>Rubbo</surname><given-names>PA</given-names></name><name><surname>Lortholary</surname><given-names>O</given-names></name><name><surname>Montes</surname><given-names>B</given-names></name><etal/></person-group><article-title>Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS</article-title><source>Aids</source><year>2012</year><volume>26</volume><fpage>2110</fpage><lpage>2112</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e328358daea</pub-id><?supplied-pmid 22874513?><pub-id pub-id-type="pmid">22874513</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>GC</given-names></name><name><surname>Vieira</surname><given-names>MA</given-names></name><name><surname>Lourenco</surname><given-names>MC</given-names></name><name><surname>Gadelha</surname><given-names>AJ</given-names></name><name><surname>Coura</surname><given-names>LC</given-names></name><name><surname>Rolla</surname><given-names>VC</given-names></name></person-group><article-title>Inflammatory paradoxical reaction occurring in tuberculosis patients treated with HAART and rifampicin</article-title><source>Rev Inst Med Trop Sao Paulo</source><year>2002</year><volume>44</volume><fpage>113</fpage><lpage>114</lpage><?supplied-pmid 12048550?><pub-id pub-id-type="pmid">12048550</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lortholary</surname><given-names>O</given-names></name><name><surname>Fontanet</surname><given-names>A</given-names></name><name><surname>Memain</surname><given-names>N</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Sitbon</surname><given-names>K</given-names></name><name><surname>Dromer</surname><given-names>F</given-names></name><etal/></person-group><article-title>Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France</article-title><source>Aids</source><year>2005</year><volume>19</volume><fpage>1043</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1097/01.aids.0000174450.70874.30</pub-id><?supplied-pmid 15958835?><pub-id pub-id-type="pmid">15958835</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Toorn</surname><given-names>R</given-names></name><name><surname>Rabie</surname><given-names>H</given-names></name><name><surname>Dramowski</surname><given-names>A</given-names></name><name><surname>Schoeman</surname><given-names>JF</given-names></name></person-group><article-title>Neurological manifestations of TB-IRIS: a report of 4 children</article-title><source>Eur J Paediatr Neurol</source><year>2012</year><volume>16</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1016/j.ejpn.2012.04.005</pub-id><?supplied-pmid 22658306?><pub-id pub-id-type="pmid">22658306</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Oland</surname><given-names>SD</given-names></name><name><surname>Amaral</surname><given-names>EP</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Gonzales</surname><given-names>J</given-names></name><etal/></person-group><article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title><source>Nature</source><year>2014</year><volume>511</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nature13489</pub-id><?supplied-pmid 24990750?><pub-id pub-id-type="pmid">24990750</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardwick</surname><given-names>C</given-names></name><name><surname>White</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>E</given-names></name><name><surname>Monteiro</surname><given-names>EF</given-names></name><name><surname>Breen</surname><given-names>RA</given-names></name><name><surname>Lipman</surname><given-names>M</given-names></name></person-group><article-title>Montelukast in the treatment of HIV associated immune reconstitution disease</article-title><source>Sex Transm Infect</source><year>2006</year><volume>82</volume><fpage>513</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1136/sti.2005.017863</pub-id><?supplied-pmid 17151039?><pub-id pub-id-type="pmid">17151039</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipman</surname><given-names>MC</given-names></name><name><surname>Carding</surname><given-names>SK</given-names></name></person-group><article-title>Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?</article-title><source>Aids</source><year>2007</year><volume>21</volume><fpage>383</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e328011cb38</pub-id><?supplied-pmid 17255752?><pub-id pub-id-type="pmid">17255752</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>HC</given-names></name><name><surname>Heath</surname><given-names>CH</given-names></name><name><surname>French</surname><given-names>MA</given-names></name></person-group><article-title>Pulmonary <italic>Mycobacterium celatum</italic> immune restoration disease: immunopathology and response to corticosteroid therapy</article-title><source>Aids</source><year>2005</year><volume>19</volume><fpage>2047</fpage><lpage>2049</lpage><pub-id pub-id-type="doi">10.1097/01.aids.0000191228.36797.5b</pub-id><?supplied-pmid 16260918?><pub-id pub-id-type="pmid">16260918</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boelaert</surname><given-names>JR</given-names></name><name><surname>Goddeeris</surname><given-names>KH</given-names></name><name><surname>Vanopdenbosch</surname><given-names>LJ</given-names></name><name><surname>Casselman</surname><given-names>JW</given-names></name></person-group><article-title>Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy</article-title><source>Aids</source><year>2004</year><volume>18</volume><fpage>1223</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1097/00002030-200405210-00023</pub-id><?supplied-pmid 15166545?><pub-id pub-id-type="pmid">15166545</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>M</given-names></name><name><surname>French</surname><given-names>MA</given-names></name></person-group><article-title>Exacerbation of the inflammatory response to <italic>Mycobacterium tuberculosis</italic> after antiretroviral therapy</article-title><source>Med J Aust</source><year>1998</year><volume>169</volume><fpage>473</fpage><lpage>474</lpage><?supplied-pmid 9847899?><pub-id pub-id-type="pmid">9847899</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Okwera</surname><given-names>A</given-names></name><name><surname>Nsubuga</surname><given-names>P</given-names></name><name><surname>Whalen</surname><given-names>CC</given-names></name><name><surname>Mugerwa</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Pentoxifylline in human immunodeficiency virus- positive tuberculosis: safety at 4 years</article-title><source>J Infect Dis</source><year>1998</year><volume>178</volume><fpage>1861</fpage><pub-id pub-id-type="doi">10.1086/314528</pub-id><?supplied-pmid 9815253?><pub-id pub-id-type="pmid">9815253</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>van Vuuren</surname><given-names>C</given-names></name><name><surname>Potgieter</surname><given-names>S</given-names></name></person-group><article-title>Adalimumab treatment of life-threatening tuberculosis</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><fpage>1429</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.1086/598504</pub-id><?supplied-pmid 19364287?><pub-id pub-id-type="pmid">19364287</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>SO</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Woo</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis</article-title><source>J Infect Chemother</source><year>2012</year><volume>18</volume><fpage>555</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1007/s10156-011-0334-y</pub-id><?supplied-pmid 22045163?><pub-id pub-id-type="pmid">22045163</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackmore</surname><given-names>TK</given-names></name><name><surname>Manning</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>WJ</given-names></name><name><surname>Wallis</surname><given-names>RS</given-names></name></person-group><article-title>Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes</article-title><source>Clin Infect Dis</source><year>2008</year><volume>47</volume><fpage>e83</fpage><lpage>e85</lpage><pub-id pub-id-type="doi">10.1086/592695</pub-id><?supplied-pmid 18840076?><pub-id pub-id-type="pmid">18840076</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitapati</surname><given-names>AM</given-names></name><name><surname>Kao</surname><given-names>CL</given-names></name><name><surname>Cachay</surname><given-names>ER</given-names></name><name><surname>Masoumi</surname><given-names>H</given-names></name><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>Mathews</surname><given-names>WC</given-names></name></person-group><article-title>Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab</article-title><source>Clin Infect Dis</source><year>2010</year><volume>50</volume><fpage>e7</fpage><lpage>e10</lpage><pub-id pub-id-type="doi">10.1086/649553</pub-id><?supplied-pmid 20001539?><pub-id pub-id-type="pmid">20001539</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravimohan</surname><given-names>S</given-names></name><name><surname>Tamuhla</surname><given-names>N</given-names></name><name><surname>Steenhoff</surname><given-names>AP</given-names></name><name><surname>Letlhogile</surname><given-names>R</given-names></name><name><surname>Nfanyana</surname><given-names>K</given-names></name><name><surname>Bellamy</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study</article-title><source>Lancet Infect Dis</source><year>2015</year><volume>15</volume><fpage>429</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(15)70008-3</pub-id><?supplied-pmid 25672566?><pub-id pub-id-type="pmid">25672566</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadokera</surname><given-names>R</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Skolimowska</surname><given-names>KH</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Matthews</surname><given-names>K</given-names></name><name><surname>Seldon</surname><given-names>R</given-names></name><etal/></person-group><article-title>Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome</article-title><source>Eur Respir J</source><year>2011</year><volume>37</volume><fpage>1248</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1183/09031936.00091010</pub-id><?supplied-pmid 20817712?><pub-id pub-id-type="pmid">20817712</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breton</surname><given-names>G</given-names></name><name><surname>Duval</surname><given-names>X</given-names></name><name><surname>Estellat</surname><given-names>C</given-names></name><name><surname>Poaletti</surname><given-names>X</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><name><surname>Mvondo Mvondo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy</article-title><source>Clin Infect Dis</source><year>2004</year><volume>39</volume><fpage>1709</fpage><lpage>1712</lpage><pub-id pub-id-type="doi">10.1086/425742</pub-id><?supplied-pmid 15578375?><pub-id pub-id-type="pmid">15578375</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Skolimowska</surname><given-names>K</given-names></name><name><surname>van Veen</surname><given-names>K</given-names></name><name><surname>Abrahams</surname><given-names>M</given-names></name><etal/></person-group><article-title>Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>178</volume><fpage>1083</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1164/rccm.200806-858OC</pub-id><?supplied-pmid 18755923?><pub-id pub-id-type="pmid">18755923</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tieu</surname><given-names>HV</given-names></name><name><surname>Ananworanich</surname><given-names>J</given-names></name><name><surname>Avihingsanon</surname><given-names>A</given-names></name><name><surname>Apateerapong</surname><given-names>W</given-names></name><name><surname>Sirivichayakul</surname><given-names>S</given-names></name><name><surname>Siangphoe</surname><given-names>U</given-names></name><etal/></person-group><article-title>Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand</article-title><source>AIDS Res Hum Retrovir</source><year>2009</year><volume>25</volume><fpage>1083</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1089/aid.2009.0055</pub-id><?supplied-pmid 19886838?><pub-id pub-id-type="pmid">19886838</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>JH</given-names></name><name><surname>Vohith</surname><given-names>K</given-names></name><name><surname>Saramony</surname><given-names>S</given-names></name><name><surname>Savuth</surname><given-names>C</given-names></name><name><surname>Dara</surname><given-names>C</given-names></name><name><surname>Sarim</surname><given-names>C</given-names></name><etal/></person-group><article-title>Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy</article-title><source>J Infect Dis</source><year>2009</year><volume>200</volume><fpage>1736</fpage><lpage>1745</lpage><pub-id pub-id-type="doi">10.1086/644784</pub-id><?supplied-pmid 19874177?><pub-id pub-id-type="pmid">19874177</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Mahnke</surname><given-names>Y</given-names></name><name><surname>Hodge</surname><given-names>JN</given-names></name><name><surname>Porter</surname><given-names>BO</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>DerSimonian</surname><given-names>R</given-names></name><etal/></person-group><article-title>Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>3818</fpage><lpage>3827</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-05-285080</pub-id><?supplied-pmid 20660788?><pub-id pub-id-type="pmid">20660788</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>LA</given-names></name><name><surname>Boucherie</surname><given-names>C</given-names></name><name><surname>Bugault</surname><given-names>F</given-names></name><name><surname>Cumont</surname><given-names>MC</given-names></name><name><surname>Roussillon</surname><given-names>C</given-names></name><name><surname>Breton</surname><given-names>G</given-names></name><etal/></person-group><article-title>Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>Aids</source><year>2014</year><volume>28</volume><fpage>1593</fpage><lpage>1602</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000311</pub-id><?supplied-pmid 24865974?><pub-id pub-id-type="pmid">24865974</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahnke</surname><given-names>YD</given-names></name><name><surname>Greenwald</surname><given-names>JH</given-names></name><name><surname>DerSimonian</surname><given-names>R</given-names></name><name><surname>Roby</surname><given-names>G</given-names></name><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><etal/></person-group><article-title>Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>3105</fpage><lpage>3112</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-09-380840</pub-id><?supplied-pmid 22219223?><pub-id pub-id-type="pmid">22219223</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name></person-group><article-title>Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><fpage>345</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1038/ni1178</pub-id><?supplied-pmid 15785760?><pub-id pub-id-type="pmid">15785760</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott-Browne</surname><given-names>JP</given-names></name><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Tucker-Heard</surname><given-names>G</given-names></name><name><surname>Ishida-Tsubota</surname><given-names>K</given-names></name><name><surname>Fontenot</surname><given-names>JD</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name><etal/></person-group><article-title>Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis</article-title><source>J Exp Med</source><year>2007</year><volume>204</volume><fpage>2159</fpage><lpage>2169</lpage><pub-id pub-id-type="doi">10.1084/jem.20062105</pub-id><?supplied-pmid 17709423?><pub-id pub-id-type="pmid">17709423</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyot-Revol</surname><given-names>V</given-names></name><name><surname>Innes</surname><given-names>JA</given-names></name><name><surname>Hackforth</surname><given-names>S</given-names></name><name><surname>Hinks</surname><given-names>T</given-names></name><name><surname>Lalvani</surname><given-names>A</given-names></name></person-group><article-title>Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>173</volume><fpage>803</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1164/rccm.200508-1294OC</pub-id><?supplied-pmid 16339919?><pub-id pub-id-type="pmid">16339919</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddiki</surname><given-names>N</given-names></name><name><surname>Sasson</surname><given-names>SC</given-names></name><name><surname>Santner-Nanan</surname><given-names>B</given-names></name><name><surname>Munier</surname><given-names>M</given-names></name><name><surname>van Bockel</surname><given-names>D</given-names></name><name><surname>Ip</surname><given-names>S</given-names></name><etal/></person-group><article-title>Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease</article-title><source>Eur J Immunol</source><year>2009</year><volume>39</volume><fpage>391</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1002/eji.200838630</pub-id><?supplied-pmid 19180462?><pub-id pub-id-type="pmid">19180462</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>DB</given-names></name><name><surname>Yong</surname><given-names>YK</given-names></name><name><surname>Tan</surname><given-names>HY</given-names></name><name><surname>Kamarulzaman</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>LH</given-names></name><name><surname>Lim</surname><given-names>A</given-names></name><etal/></person-group><article-title>Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis</article-title><source>HIV Med</source><year>2008</year><volume>9</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1293.2008.00565.x</pub-id><?supplied-pmid 18400078?><pub-id pub-id-type="pmid">18400078</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Mallevaey</surname><given-names>T</given-names></name><name><surname>Scott-Browne</surname><given-names>J</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name></person-group><article-title>CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system</article-title><source>Curr Opin Immunol</source><year>2008</year><volume>20</volume><fpage>358</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2008.03.018</pub-id><?supplied-pmid 18501573?><pub-id pub-id-type="pmid">18501573</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>RE</given-names></name><name><surname>Chervenak</surname><given-names>KA</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Morrow</surname><given-names>J</given-names></name><name><surname>Nshuti</surname><given-names>L</given-names></name><name><surname>Zalwango</surname><given-names>S</given-names></name><etal/></person-group><article-title>Vdelta2+ gammadelta T cell function in <italic>Mycobacterium tuberculosis</italic>- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay</article-title><source>J Infect Dis</source><year>2005</year><volume>192</volume><fpage>1806</fpage><lpage>1814</lpage><pub-id pub-id-type="doi">10.1086/497146</pub-id><?supplied-pmid 16235181?><pub-id pub-id-type="pmid">16235181</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Qiu</surname><given-names>L</given-names></name><name><surname>Lai</surname><given-names>X</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><etal/></person-group><article-title>Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections</article-title><source>Science</source><year>2002</year><volume>295</volume><fpage>2255</fpage><lpage>2258</lpage><pub-id pub-id-type="doi">10.1126/science.1068819</pub-id><?supplied-pmid 11910108?><pub-id pub-id-type="pmid">11910108</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabelitz</surname><given-names>D</given-names></name><name><surname>Bender</surname><given-names>A</given-names></name><name><surname>Schondelmaier</surname><given-names>S</given-names></name><name><surname>Schoel</surname><given-names>B</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>A large fraction of human peripheral blood gamma/delta&#x02009;+&#x02009;T cells is activated by <italic>Mycobacterium tuberculosis</italic> but not by its 65-kD heat shock protein</article-title><source>J Exp Med</source><year>1990</year><volume>171</volume><fpage>667</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1084/jem.171.3.667</pub-id><?supplied-pmid 2137854?><pub-id pub-id-type="pmid">2137854</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gioia</surname><given-names>C</given-names></name><name><surname>Agrati</surname><given-names>C</given-names></name><name><surname>Casetti</surname><given-names>R</given-names></name><name><surname>Cairo</surname><given-names>C</given-names></name><name><surname>Borsellino</surname><given-names>G</given-names></name><name><surname>Battistini</surname><given-names>L</given-names></name><etal/></person-group><article-title>Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>1484</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.3.1484</pub-id><?supplied-pmid 11801693?><pub-id pub-id-type="pmid">11801693</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgarit</surname><given-names>A</given-names></name><name><surname>Carcelain</surname><given-names>G</given-names></name><name><surname>Samri</surname><given-names>A</given-names></name><name><surname>Parizot</surname><given-names>C</given-names></name><name><surname>Lafaurie</surname><given-names>M</given-names></name><name><surname>Abgrall</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells</article-title><source>J Immunol</source><year>2009</year><volume>183</volume><fpage>3915</fpage><lpage>3923</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0804020</pub-id><?supplied-pmid 19726768?><pub-id pub-id-type="pmid">19726768</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Walker</surname><given-names>NF</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Deffur</surname><given-names>A</given-names></name><name><surname>Nicol</surname><given-names>MP</given-names></name><name><surname>Skolimowska</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Cytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome</article-title><source>J Immunol</source><year>2015</year><volume>194</volume><fpage>1748</fpage><lpage>1754</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1402105</pub-id><?supplied-pmid 25589068?><pub-id pub-id-type="pmid">25589068</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa</surname><given-names>E</given-names></name><name><surname>Ormsby</surname><given-names>CE</given-names></name><name><surname>Vega-Barrientos</surname><given-names>RS</given-names></name><name><surname>Ruiz-Cruz</surname><given-names>M</given-names></name><name><surname>Moreno-Coutino</surname><given-names>G</given-names></name><name><surname>Pena-Jimenez</surname><given-names>A</given-names></name><etal/></person-group><article-title>Risk factors for immune reconstitution inflammatory syndrome under combination antiretroviral therapy can be aetiology-specific</article-title><source>Int J STD AIDS</source><year>2010</year><volume>21</volume><fpage>573</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1258/ijsa.2010.010135</pub-id><?supplied-pmid 20975091?><pub-id pub-id-type="pmid">20975091</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>A</given-names></name><name><surname>D'Orsogna</surname><given-names>L</given-names></name><name><surname>Price</surname><given-names>P</given-names></name><name><surname>French</surname><given-names>MA</given-names></name></person-group><article-title>Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease</article-title><source>AIDS Res Ther</source><year>2008</year><volume>5</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1186/1742-6405-5-9</pub-id><?supplied-pmid 18442415?><pub-id pub-id-type="pmid">18442415</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skolimowska</surname><given-names>KH</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Pepper</surname><given-names>DJ</given-names></name><name><surname>Seldon</surname><given-names>R</given-names></name><name><surname>Matthews</surname><given-names>K</given-names></name><etal/></person-group><article-title>Altered ratio of IFN-gamma/IL-10 in patients with drug resistant <italic>Mycobacterium tuberculosis</italic> and HIV-Tuberculosis Immune Reconstitution Inflammatory Syndrome</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><pub-id pub-id-type="doi">10.1371/journal.pone.0046481</pub-id><?supplied-pmid 23071578?><pub-id pub-id-type="pmid">23071578</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>PM</given-names></name><name><surname>Komarow</surname><given-names>L</given-names></name><name><surname>Lederman</surname><given-names>MM</given-names></name><name><surname>Pahwa</surname><given-names>S</given-names></name><name><surname>Zolopa</surname><given-names>AR</given-names></name><name><surname>Andersen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164</article-title><source>J Infect Dis</source><year>2012</year><volume>206</volume><fpage>1715</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis604</pub-id><?supplied-pmid 23002445?><pub-id pub-id-type="pmid">23002445</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morlese</surname><given-names>JF</given-names></name><name><surname>Orkin</surname><given-names>CM</given-names></name><name><surname>Abbas</surname><given-names>R</given-names></name><name><surname>Burton</surname><given-names>C</given-names></name><name><surname>Qazi</surname><given-names>NA</given-names></name><name><surname>Nelson</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection</article-title><source>Aids</source><year>2003</year><volume>17</volume><fpage>1411</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1097/00002030-200306130-00025</pub-id><?supplied-pmid 12799572?><pub-id pub-id-type="pmid">12799572</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worsley</surname><given-names>CM</given-names></name><name><surname>Suchard</surname><given-names>MS</given-names></name><name><surname>Stevens</surname><given-names>WS</given-names></name><name><surname>Van Rie</surname><given-names>A</given-names></name><name><surname>Murdoch</surname><given-names>DM</given-names></name></person-group><article-title>Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS)</article-title><source>AIDS Res Ther</source><year>2010</year><volume>7</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/1742-6405-7-36</pub-id><?supplied-pmid 20929543?><pub-id pub-id-type="pmid">20929543</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narendran</surname><given-names>G</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Porter</surname><given-names>BO</given-names></name><name><surname>Chandrasekhar</surname><given-names>C</given-names></name><name><surname>Venkatesan</surname><given-names>P</given-names></name><name><surname>Menon</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><pub-id pub-id-type="doi">10.1371/journal.pone.0063541</pub-id><?supplied-pmid 23691062?><pub-id pub-id-type="pmid">23691062</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>McBerry</surname><given-names>C</given-names></name><name><surname>Sereti</surname><given-names>I</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><article-title>Role of IL-6 in <italic>Mycobacterium avium</italic>-associated immune reconstitution inflammatory syndrome</article-title><source>J Immunol</source><year>2014</year><volume>192</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301004</pub-id><?supplied-pmid 24337386?><pub-id pub-id-type="pmid">24337386</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadokera</surname><given-names>R</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Meintjes</surname><given-names>GA</given-names></name><name><surname>Skolimowska</surname><given-names>KH</given-names></name><name><surname>Matthews</surname><given-names>K</given-names></name><name><surname>Seldon</surname><given-names>R</given-names></name><etal/></person-group><article-title>Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis</article-title><source>J Infect Dis</source><year>2013</year><volume>207</volume><fpage>1148</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit002</pub-id><?supplied-pmid 23303806?><pub-id pub-id-type="pmid">23303806</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Gaffen</surname><given-names>SL</given-names></name><name><surname>Kolls</surname><given-names>JK</given-names></name></person-group><article-title>Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa</article-title><source>Mucosal Immunol</source><year>2009</year><volume>2</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1038/mi.2009.100</pub-id><?supplied-pmid 19587639?><pub-id pub-id-type="pmid">19587639</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>BG</given-names></name><name><surname>Elliott</surname><given-names>JH</given-names></name><name><surname>Price</surname><given-names>P</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Saphonn</surname><given-names>V</given-names></name><name><surname>Vun</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with <italic>Mycobacterium tuberculosis</italic> in HIV patients beginning antiretroviral therapy</article-title><source>J Infect Dis</source><year>2010</year><volume>202</volume><fpage>1728</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1086/657082</pub-id><?supplied-pmid 20977362?><pub-id pub-id-type="pmid">20977362</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>HY</given-names></name><name><surname>Yong</surname><given-names>YK</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Shankar</surname><given-names>EM</given-names></name><name><surname>Ponnampalavanar</surname><given-names>S</given-names></name><name><surname>Omar</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>Aids</source><year>2015</year><volume>29</volume><fpage>421</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000557</pub-id><?supplied-pmid 25565499?><pub-id pub-id-type="pmid">25565499</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conesa-Botella</surname><given-names>A</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Coussens</surname><given-names>AK</given-names></name><name><surname>van der Plas</surname><given-names>H</given-names></name><name><surname>Goliath</surname><given-names>R</given-names></name><name><surname>Schutz</surname><given-names>C</given-names></name><etal/></person-group><article-title>Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome</article-title><source>Clin Infect Dis</source><year>2012</year><volume>55</volume><fpage>1004</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1093/cid/cis577</pub-id><?supplied-pmid 22715179?><pub-id pub-id-type="pmid">22715179</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marais</surname><given-names>S</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Lesosky</surname><given-names>M</given-names></name><name><surname>Coussens</surname><given-names>AK</given-names></name><name><surname>Deffur</surname><given-names>A</given-names></name><name><surname>Pepper</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome</article-title><source>Clin Infect Dis</source><year>2014</year><volume>59</volume><fpage>1638</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu641</pub-id><?supplied-pmid 25107295?><pub-id pub-id-type="pmid">25107295</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueders</surname><given-names>MM</given-names></name><name><surname>Foidart</surname><given-names>JM</given-names></name><name><surname>Noel</surname><given-names>A</given-names></name><name><surname>Cataldo</surname><given-names>DD</given-names></name></person-group><article-title>Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases</article-title><source>Eur J Pharmacol</source><year>2006</year><volume>533</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2005.12.082</pub-id><?supplied-pmid 16487964?><pub-id pub-id-type="pmid">16487964</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>KJ</given-names></name><name><surname>Hwang</surname><given-names>SC</given-names></name><name><surname>Sheen</surname><given-names>SS</given-names></name><name><surname>Oh</surname><given-names>YJ</given-names></name><name><surname>Han</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KB</given-names></name></person-group><article-title>Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer</article-title><source>Respir Int Rev Thoracic Dis</source><year>2005</year><volume>72</volume><fpage>166</fpage><lpage>175</lpage></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkington</surname><given-names>P</given-names></name><name><surname>Shiomi</surname><given-names>T</given-names></name><name><surname>Breen</surname><given-names>R</given-names></name><name><surname>Nuttall</surname><given-names>RK</given-names></name><name><surname>Ugarte-Gil</surname><given-names>CA</given-names></name><name><surname>Walker</surname><given-names>NF</given-names></name><etal/></person-group><article-title>MMP-1 drives immunopathology in human tuberculosis and transgenic mice</article-title><source>J Clin Invest</source><year>2011</year><volume>121</volume><fpage>1827</fpage><lpage>1833</lpage><pub-id pub-id-type="doi">10.1172/JCI45666</pub-id><?supplied-pmid 21519144?><pub-id pub-id-type="pmid">21519144</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadokera</surname><given-names>R</given-names></name><name><surname>Meintjes</surname><given-names>GA</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Skolimowska</surname><given-names>KH</given-names></name><name><surname>Walker</surname><given-names>N</given-names></name><name><surname>Friedland</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome</article-title><source>Eur J Immunol</source><year>2014</year><volume>44</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1002/eji.201343593</pub-id><?supplied-pmid 24136296?><pub-id pub-id-type="pmid">24136296</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>AR</given-names></name><name><surname>Nhamoyebonde</surname><given-names>S</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Marais</surname><given-names>S</given-names></name><name><surname>Bangani</surname><given-names>N</given-names></name><etal/></person-group><article-title>Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><fpage>19013</fpage><lpage>19017</lpage><pub-id pub-id-type="doi">10.1073/pnas.1111825108</pub-id><?supplied-pmid 22025704?><pub-id pub-id-type="pmid">22025704</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coussens</surname><given-names>A</given-names></name><name><surname>Timms</surname><given-names>PM</given-names></name><name><surname>Boucher</surname><given-names>BJ</given-names></name><name><surname>Venton</surname><given-names>TR</given-names></name><name><surname>Ashcroft</surname><given-names>AT</given-names></name><name><surname>Skolimowska</surname><given-names>KH</given-names></name><etal/></person-group><article-title>1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Immunology</source><year>2009</year><volume>127</volume><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2008.03024.x</pub-id><?supplied-pmid 19178594?><pub-id pub-id-type="pmid">19178594</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coussens</surname><given-names>AK</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Hanifa</surname><given-names>Y</given-names></name><name><surname>Nikolayevskyy</surname><given-names>V</given-names></name><name><surname>Elkington</surname><given-names>PT</given-names></name><name><surname>Islam</surname><given-names>K</given-names></name><etal/></person-group><article-title>Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><fpage>15449</fpage><lpage>15454</lpage><pub-id pub-id-type="doi">10.1073/pnas.1200072109</pub-id><?supplied-pmid 22949664?><pub-id pub-id-type="pmid">22949664</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>P</given-names></name><name><surname>Haddow</surname><given-names>LJ</given-names></name><name><surname>Affandi</surname><given-names>J</given-names></name><name><surname>Agarwal</surname><given-names>U</given-names></name><name><surname>Easterbrook</surname><given-names>PJ</given-names></name><name><surname>Elliott</surname><given-names>J</given-names></name><etal/></person-group><article-title>Short communication: plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with <italic>Mycobacterium tuberculosis</italic></article-title><source>AIDS Res Hum Retrovir</source><year>2012</year><volume>28</volume><fpage>1216</fpage><lpage>1219</lpage><pub-id pub-id-type="doi">10.1089/aid.2011.0272</pub-id><?supplied-pmid 22280097?><pub-id pub-id-type="pmid">22280097</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>P</given-names></name><name><surname>Morahan</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Stone</surname><given-names>E</given-names></name><name><surname>Cheong</surname><given-names>KY</given-names></name><name><surname>Castley</surname><given-names>A</given-names></name><etal/></person-group><article-title>Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases</article-title><source>Aids</source><year>2002</year><volume>16</volume><fpage>2043</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1097/00002030-200210180-00009</pub-id><?supplied-pmid 12370503?><pub-id pub-id-type="pmid">12370503</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Affandi</surname><given-names>JS</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Agarwal</surname><given-names>U</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Price</surname><given-names>P</given-names></name></person-group><article-title>The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with <italic>Mycobacterium tuberculosis</italic></article-title><source>Dis Markers</source><year>2013</year><volume>34</volume><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1155/2013/246017</pub-id><?supplied-pmid 23594560?><pub-id pub-id-type="pmid">23594560</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonney</surname><given-names>N</given-names></name><name><surname>Dewulf</surname><given-names>G</given-names></name><name><surname>Herrmann</surname><given-names>JL</given-names></name><name><surname>Gutierrez</surname><given-names>MC</given-names></name><name><surname>Vicaut</surname><given-names>E</given-names></name><name><surname>Boutron</surname><given-names>C</given-names></name><etal/></person-group><article-title>Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients</article-title><source>Tuberculosis</source><year>2008</year><volume>88</volume><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2008.01.006</pub-id><?supplied-pmid 18495539?><pub-id pub-id-type="pmid">18495539</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumatoh</surname><given-names>HR</given-names></name><name><surname>Oliver</surname><given-names>BG</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Elliott</surname><given-names>JH</given-names></name><name><surname>Vonthanak</surname><given-names>S</given-names></name><name><surname>Vun</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia</article-title><source>Biomark Med</source><year>2011</year><volume>5</volume><fpage>847</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.2217/bmm.11.79</pub-id><?supplied-pmid 22103621?><pub-id pub-id-type="pmid">22103621</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phuah</surname><given-names>JY</given-names></name><name><surname>Mattila</surname><given-names>JT</given-names></name><name><surname>Lin</surname><given-names>PL</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group><article-title>Activated B cells in the granulomas of nonhuman primates infected with <italic>Mycobacterium tuberculosis</italic></article-title><source>Am J Pathol</source><year>2012</year><volume>181</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.05.009</pub-id><?supplied-pmid 22721647?><pub-id pub-id-type="pmid">22721647</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Stanley</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><etal/></person-group><article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis</article-title><source>Genes Immun</source><year>2011</year><volume>12</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/gene.2010.51</pub-id><?supplied-pmid 20861863?><pub-id pub-id-type="pmid">20861863</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><mixed-citation publication-type="other">Lai RP, Meintjes G, Wilkinson KA, Graham CM, Marais S, van der Plas H et al (2015) HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by toll-like-receptor and inflammasome signaling. Nat Commun 6:8451</mixed-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Bergh</surname><given-names>R</given-names></name><name><surname>Vanham</surname><given-names>G</given-names></name><name><surname>Raes</surname><given-names>G</given-names></name><name><surname>De Baetselier</surname><given-names>P</given-names></name><name><surname>Colebunders</surname><given-names>R</given-names></name></person-group><article-title>Mycobacterium-associated immune reconstitution disease: macrophages running wild?</article-title><source>Lancet Infect Dis</source><year>2006</year><volume>6</volume><fpage>2</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70302-9</pub-id><?supplied-pmid 16377524?><pub-id pub-id-type="pmid">16377524</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicala</surname><given-names>C</given-names></name><name><surname>Arthos</surname><given-names>J</given-names></name><name><surname>Martinelli</surname><given-names>E</given-names></name><name><surname>Censoplano</surname><given-names>N</given-names></name><name><surname>Cruz</surname><given-names>CC</given-names></name><name><surname>Chung</surname><given-names>E</given-names></name><etal/></person-group><article-title>R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>3746</fpage><lpage>3751</lpage><pub-id pub-id-type="doi">10.1073/pnas.0511237103</pub-id><?supplied-pmid 16505369?><pub-id pub-id-type="pmid">16505369</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudhane</surname><given-names>A</given-names></name><name><surname>Conti</surname><given-names>B</given-names></name><name><surname>Orlikowsky</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>ZQ</given-names></name><name><surname>Mangla</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><etal/></person-group><article-title>Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity</article-title><source>AIDS Res Hum Retrovir</source><year>1996</year><volume>12</volume><fpage>885</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1089/aid.1996.12.885</pub-id><?supplied-pmid 8798973?><pub-id pub-id-type="pmid">8798973</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulliam</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Rempel</surname><given-names>H</given-names></name></person-group><article-title>Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load</article-title><source>J Neuroimmunol</source><year>2004</year><volume>157</volume><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2004.08.039</pub-id><?supplied-pmid 15579285?><pub-id pub-id-type="pmid">15579285</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Wainwright</surname><given-names>H</given-names></name><name><surname>Orrell</surname><given-names>C</given-names></name></person-group><article-title>Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages</article-title><source>Aids</source><year>2009</year><volume>23</volume><fpage>143</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e32831d2a98</pub-id><?supplied-pmid 19050399?><pub-id pub-id-type="pmid">19050399</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>HT</given-names></name><name><surname>Van den Bergh</surname><given-names>R</given-names></name><name><surname>Loembe</surname><given-names>MM</given-names></name><name><surname>Worodria</surname><given-names>W</given-names></name><name><surname>Mayanja-Kizza</surname><given-names>H</given-names></name><name><surname>Colebunders</surname><given-names>R</given-names></name><etal/></person-group><article-title>Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>Aids</source><year>2013</year><volume>27</volume><fpage>1725</fpage><lpage>1734</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e328361648b</pub-id><?supplied-pmid 23807270?><pub-id pub-id-type="pmid">23807270</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>HT</given-names></name><name><surname>Van den Bergh</surname><given-names>R</given-names></name><name><surname>Vu</surname><given-names>TN</given-names></name><name><surname>Laukens</surname><given-names>K</given-names></name><name><surname>Worodria</surname><given-names>W</given-names></name><name><surname>Loembe</surname><given-names>MM</given-names></name><etal/></person-group><article-title>The role of monocytes in the development of tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>Immunobiology</source><year>2014</year><volume>219</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2013.07.004</pub-id><?supplied-pmid 23958034?><pub-id pub-id-type="pmid">23958034</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunkelberger</surname><given-names>JR</given-names></name><name><surname>Song</surname><given-names>WC</given-names></name></person-group><article-title>Complement and its role in innate and adaptive immune responses</article-title><source>Cell Res</source><year>2010</year><volume>20</volume><fpage>34</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/cr.2009.139</pub-id><?supplied-pmid 20010915?><pub-id pub-id-type="pmid">20010915</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Narendran</surname><given-names>G</given-names></name><name><surname>Schechter</surname><given-names>ME</given-names></name><name><surname>Nayak</surname><given-names>K</given-names></name><name><surname>Subramanian</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><pub-id pub-id-type="doi">10.1371/journal.ppat.1004433</pub-id><?supplied-pmid 25275318?><pub-id pub-id-type="pmid">25275318</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Barnes</surname><given-names>PF</given-names></name><name><surname>Garg</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Vankayalapati</surname><given-names>R</given-names></name></person-group><article-title>NK cells lyse T regulatory cells that expand in response to an intracellular pathogen</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>1729</fpage><lpage>1736</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.3.1729</pub-id><?supplied-pmid 18209070?><pub-id pub-id-type="pmid">18209070</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vankayalapati</surname><given-names>R</given-names></name><name><surname>Wizel</surname><given-names>B</given-names></name><name><surname>Weis</surname><given-names>SE</given-names></name><name><surname>Safi</surname><given-names>H</given-names></name><name><surname>Lakey</surname><given-names>DL</given-names></name><name><surname>Mandelboim</surname><given-names>O</given-names></name><etal/></person-group><article-title>The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>3451</fpage><lpage>3457</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.7.3451</pub-id><?supplied-pmid 11907104?><pub-id pub-id-type="pmid">11907104</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vankayalapati</surname><given-names>R</given-names></name><name><surname>Klucar</surname><given-names>P</given-names></name><name><surname>Wizel</surname><given-names>B</given-names></name><name><surname>Weis</surname><given-names>SE</given-names></name><name><surname>Samten</surname><given-names>B</given-names></name><name><surname>Safi</surname><given-names>H</given-names></name><etal/></person-group><article-title>NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>130</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.1.130</pub-id><?supplied-pmid 14688318?><pub-id pub-id-type="pmid">14688318</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conradie</surname><given-names>F</given-names></name><name><surname>Foulkes</surname><given-names>AS</given-names></name><name><surname>Ive</surname><given-names>P</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Roussos</surname><given-names>K</given-names></name><name><surname>Glencross</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Natural killer cell activation distinguishes <italic>Mycobacterium tuberculosis</italic>-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection</article-title><source>J Acquir Immune Defic Syndr</source><year>2011</year><volume>58</volume><fpage>309</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e31822e0d15</pub-id><?supplied-pmid 21826013?><pub-id pub-id-type="pmid">21826013</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pean</surname><given-names>P</given-names></name><name><surname>Nerrienet</surname><given-names>E</given-names></name><name><surname>Madec</surname><given-names>Y</given-names></name><name><surname>Borand</surname><given-names>L</given-names></name><name><surname>Laureillard</surname><given-names>D</given-names></name><name><surname>Fernandez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>3315</fpage><lpage>3320</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-09-377523</pub-id><?supplied-pmid 22343919?><pub-id pub-id-type="pmid">22343919</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chackerian</surname><given-names>A</given-names></name><name><surname>Alt</surname><given-names>J</given-names></name><name><surname>Perera</surname><given-names>V</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>Activation of NKT cells protects mice from tuberculosis</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>6302</fpage><lpage>6309</lpage><pub-id pub-id-type="doi">10.1128/IAI.70.11.6302-6309.2002</pub-id><?supplied-pmid 12379709?><pub-id pub-id-type="pmid">12379709</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Yeremeev</surname><given-names>V</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>3rd</suffix></name><name><surname>Jorg</surname><given-names>S</given-names></name><name><surname>Heinemann</surname><given-names>E</given-names></name><etal/></person-group><article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics</article-title><source>Eur J Immunol</source><year>2014</year><volume>44</volume><fpage>2380</fpage><lpage>2393</lpage><pub-id pub-id-type="doi">10.1002/eji.201344219</pub-id><?supplied-pmid 24782112?><pub-id pub-id-type="pmid">24782112</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>B</given-names></name><name><surname>Thieblemont</surname><given-names>N</given-names></name><name><surname>Quesniaux</surname><given-names>VJ</given-names></name><name><surname>Brown</surname><given-names>N</given-names></name><name><surname>Mpagi</surname><given-names>J</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><etal/></person-group><article-title>Toll-like receptor 4 expression is required to control chronic <italic>Mycobacterium tuberculosis</italic> infection in mice</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>3155</fpage><lpage>3162</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.6.3155</pub-id><?supplied-pmid 12218133?><pub-id pub-id-type="pmid">12218133</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiling</surname><given-names>N</given-names></name><name><surname>Holscher</surname><given-names>C</given-names></name><name><surname>Fehrenbach</surname><given-names>A</given-names></name><name><surname>Kroger</surname><given-names>S</given-names></name><name><surname>Kirschning</surname><given-names>CJ</given-names></name><name><surname>Goyert</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>3480</fpage><lpage>3484</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.7.3480</pub-id><?supplied-pmid 12244136?><pub-id pub-id-type="pmid">12244136</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>DB</given-names></name><name><surname>Lim</surname><given-names>A</given-names></name><name><surname>Yong</surname><given-names>YK</given-names></name><name><surname>Ponnampalavanar</surname><given-names>S</given-names></name><name><surname>Omar</surname><given-names>S</given-names></name><name><surname>Kamarulzaman</surname><given-names>A</given-names></name><etal/></person-group><article-title>TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease</article-title><source>Aids</source><year>2011</year><volume>25</volume><fpage>1455</fpage><lpage>1460</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e328348fb18</pub-id><?supplied-pmid 21610488?><pub-id pub-id-type="pmid">21610488</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Wilson</surname><given-names>MS</given-names></name><name><surname>White</surname><given-names>S</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><etal/></person-group><article-title>Th1-driven immune reconstitution disease in <italic>Mycobacterium avium</italic>-infected mice</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>3485</fpage><lpage>3493</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-05-286336</pub-id><?supplied-pmid 20656932?><pub-id pub-id-type="pmid">20656932</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatziioannou</surname><given-names>T</given-names></name><name><surname>Evans</surname><given-names>DT</given-names></name></person-group><article-title>Animal models for HIV/AIDS research</article-title><source>Nat Rev Microbiol</source><year>2012</year><volume>10</volume><fpage>852</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2911</pub-id><?supplied-pmid 23154262?><pub-id pub-id-type="pmid">23154262</pub-id></element-citation></ref></